Identification of chromosome 3 epigenetic and genetic abnormalities and gene expression changes in ovarian cancer

Biopolymers and Cell

Volumn 24, Issue 4, 2008, Pages 323-332

  Gordiyuk, V V ^a   Gerashchenko, G V ^a   Skrypkina, I Ya ^a   Symonchuk, O V ^b   Pavlova, T V ^c   Ugryn, D D ^a   Manzhura, E P ^d   Vakulenko, G O ^e   Zabarovsky, E R ^f   Rynditch, A V ^a   Kashuba, V I ^a,f  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d Kiev City Oncological Hospital   (Ukraine)

^e BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

DNA methylation; Gene expression; Human chromosome 3; NotI microarrays; Ovarian cancer

Indexed keywords

EID: 79952493694     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.0007B0     Document Type: Article

References (28)

1. Kokhanevich Ye. V., Vakulenko G. A., Klevetenko M. P., Simonchuk Ye. V., Sudoma I. A., Sumenko V. V. Malignant tumors of the ovary: diagnostic problem. Zdorov’ye zhenshchiny. 2004; 2(18):202–215.
2. Li J., Protopopov A., Wang F., Senchenko V., Petushkov V., Vorontsova O., Petrenko L., Zabarovska V., Muravenko O., Braga E., Kisselev L., Lerman M. I., Kashuba V., Klein G., Ernberg I., Wahlestedt C., Zabarovsky E. R. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc. Nat. Acad. Sci. USA 2002 99 P. 10724-10729.
3. Dreijerink K., Braga E., Kuzmin I., Geil L., Duh F. M., Angeloni D., Zbar B., Lerman M. I., Stanbridge E. J., Minna J. D., Protopopov A., Li J., Kashuba V., Klein G., Zabarovsky E. R. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Nat. Acad. Sci. USA 2001-98, N 13 P. 7504-7509.
4. Kashuba V. I., Li J., Wang F., Senchenko V. N., Protopopov A., Malyukova A., Kutsenko A. S., Kadyrova E., Zabarovska V. I., Muravenko O. V., Zelenin A. V., Kisselev L. L., Kuzmin I., Minna J. D., Winberg G., Ernberg I., Braga E., Lerman M. I., Klein G., Zabarovsky E. R. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc. Nat. Acad. Sci. USA 2004 101, N 14 P. 4906-4611.
5. Kashuba VI, Skripkina IIa, Saraev DV, Gordiiuk VV, Vinnitskaia AB, Tsyba LA, Pogrebnoi PV, Blinov VM, Zabarovskii ER, Ryndich AV. Identification of changes in gene loci potentially associated with cervical cancer using NotI microarrays. Ukr Biokhim Zh. 2006;78(2):113-20.
6. Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning: a laboratory manual New York: Cold Spring Harbor Lab. publ., 1982 545 p.
7. Skrypkina I. YA., Kashuba V. I., Hordyyuk V. V., Sarayev D. V., Zubko V. I., Zhonnyk YU. M., Tsyba L. A., Blinov V. M., Uhryn D. D., Mykhaylyk A. A., Yatsula B. A., Zabarovs’kyy YE. R., Ryndych A. V., Vozianov O. F. Identification of changes in gene loci potentially involved in the development of kidney cancer, with the new technology NotI-microchips. Dop. NAN Ukrayiny 2006 11:188–192.
8. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem 1987 162 P. 156-159.
9. Xu Z. M., Yu L., Lu X. C., Han W. D., Li X. J., Jing Y., Wang S. H., Jin H. J., Lon F. D. Cloning of the full length cDNA for a novel leukemia relapse-associated candidate gene LRP15. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003 11, N 1 P. 22-26.
10. Dou L. P., Wang C., Xu Z. M., Kang H. Y., Fan H., Lou F. D., Yu L. Methylation pattern of LRP15 gene in leukemia. Chin. Med. Sci. J 2007 22, N 3 P. 187-191.
11. Fazi F., Zardo G., Gelmetti V., Travaglini L., Ciolfi A., Di Croce L., Rosa A., Bozzoni I., Grignani F., Lo-Coco F., Pelicci P. G., Nervi C. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 2007 109, N 10 P. 4432-4440.
12. Pimanda J. E., Ottersbach K., Knezevic K., Kinston S., Chan W. Y., Wilson N. K., Landry J. R., Wood A. D., Kolb-Kokocinski A., Green A. R., Tannahill D., Lacaud G., Kouskoff V., Gottgens B. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc. Nat. Acad. Sci. USA 2007 104, N 45 P. 17692-17697.
13. Schneider E. M., Torlakovic E., Stuhler A., Diehl V., Tesch H., Giebel B. The early transcription factor GATA-2 is expressed in classical Hodgkin’s lymphoma. J. Pathol 2004 204, N 5 P. 538-545.
14. Umeoka K., Sanno N., Osamura R. Y., Teramoto A. Expression of GATA-2 in human pituitary adenomas. Mol. Pathol 2002 15, N 1 P. 11-17.
15. Jeong H., Kim Y. R., Kim K. N., Choe J. G., Chung J. K., Kim M. K. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl. Med. Biol 2006 33, 7 P. 875-882.
16. Lee S., Garner E. I., Welch W. R., Berkowitz R. S., Mok S. C. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinom. Gynecol. Oncol 2007 106, N 2 P. 311-317.
17. Liu Y., Sun W., Zhang K., Zheng H., Ma Y., Lin D., Zhang X., Feng L., Lei W., Zhang Z., Guo S., Han N., Tong W., Feng X., Gao Y., Cheng S. Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer 2007 56, N 3 P. 307-317.
18. Lesiak K., Sztiller-Sikorska M., Czyz M. Transcription factors in the development and progression of melanoma. Postepy Hig. Med. Dosw 2007 61 P. 576-595.
19. Ellerhorst J. A., Naderi A. A., Johnson M. K. Expression of thyrotropin-releasing hormone by human melanoma and nevi. Clin. Cancer Res 2004 10, N 1 P. 5531-5536.
20. Li X. L., Eishi Y., Bai Y. Q. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int. J. Oncol 2004 24, N 2 P. 257-263.
21. Gure A. O., Stockert E., Scanlan M. J., Keresztes R. S., Jager D., Altorki N. K., Old L. J., Chen Y. T. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc. Nat. Acad. Sci. USA 2000 97, N 8 P. 4198-4203.
22. Tsuneoka M., Koda Y., Soejima M., Teye K., Kimura H. A novel myc target gene, mina53, that is involved in cell proliferation. J. Biol. Chem 2002 277, N 3 P. 35450-35459.
23. Teye K., Tsuneoka M., Arima N. Increased expression of a Myc target gene Mina53 in human colon cancer. Amer. J. Pathol 2004 164, N 1 P. 205-216.
24. Gonzalez-Sancho J. M., García V., Bonilla F., MuZoz A. Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 2003 192, N 2 P. 121-132.
25. Li Z., Li W., Meklat F. A yeast two-hybrid system using Sp17 identified Ropporin as a novel cancer-testis antigen in hematologic malignancies. Int. J. Cancer 2007 121, N 7 P. 1507-1511.
26. Barber R. D., Harmer D. W., Coleman R. A., Clark B. J. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol. Genomics 2005 21, N 3 P. 389-395.
27. Tsuzuki S., Kitajima K., Nakano T., Glasow A., Zelent A., Enver T. Cross talk between retinoic acid signaling and transcription factor GATA-2. Mol. Cell. Biol 2004 24, N 15 P. 6824-6836.
28. Ren M., Pozzi S., Bistulfi G., Somenzi G., Rossetti S., Sacchi N. Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance. Mol. Cell. Biol 2005 25, N 23 P. 10591-10603.